Generation of Intermediate Porcine iPS Cells Under Culture Condition Favorable for Mesenchymal-to-Epithelial Transition

Stem Cell Reviews and Reports

Volumn 11, Issue 1, 2015, Pages 24-38

  Zhang, Shiqiang ^a   Guo, Yanjie ^a   Cui, Yi ^a   Liu, Yajun ^a   Yu, Tong ^a   Wang, Huayan ^a  

^a NORTHWEST A F UNIVERSITY   (China)

Author keywords

Mesenchymal epithelial transition; MicroRNA; Pig iPSC; Pluripotent state; RNA Sequencing

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 4-(5-BENZO(1,3)DIOXOL-5-YL-4-PYRIDIN-2-YL-1H-IMIDAZOL-2-YL)BENZAMIDE; 6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; BENZAMIDE DERIVATIVE; BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; LEUKEMIA INHIBITORY FACTOR; MICRORNA; MYC PROTEIN; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRANSCRIPTION FACTOR SOX; TRANSCRIPTOME;

ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CELL DIFFERENTIATION; CLUSTER ANALYSIS; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECTS; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; FLOW CYTOMETRY; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MOUSE; NUCLEAR REPROGRAMMING; PIG; PLURIPOTENT STEM CELL; PROCEDURES; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BENZAMIDES; BONE MORPHOGENETIC PROTEIN 4; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; CELLULAR REPROGRAMMING; CLUSTER ANALYSIS; DIOXOLES; EMBRYO, MAMMALIAN; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; FLOW CYTOMETRY; HEK293 CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LEUKEMIA INHIBITORY FACTOR; MICE; MICRORNAS; PROTO-ONCOGENE PROTEINS C-MYC; PYRIDINES; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOXB1 TRANSCRIPTION FACTORS; SWINE; TRANSCRIPTOME;

EID: 84939888475     PISSN: 26293269     EISSN: 26293277     Source Type: Journal    
DOI: 10.1007/s12015-014-9552-x     Document Type: Article

References (44)

1. Nichols, J., & Smith, A. (2009). Naive and primed pluripotent states. Cell Stem Cell, 4(6), 487–492.
2. Guo, G., Yang, J., Nichols, J., Hall, J. S., Eyres, I., Mansfield, W., et al. (2009). Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development, 136(7), 1063–1069.
3. Zhou, H. Y., Li, W. L., Zhu, S. Y., Joo, J. Y., Do, J. T., Xiong, W., et al. (2010). Conversion of mouse epiblast stem cells to an earlier pluripotency state by small molecules. Journal of Biological Chemistry, 285(39), 29676–29680.
4. Ying, Q. L., Wray, J., Nichols, J., Batlle-Morera, L., Doble, B., Woodgett, J., et al. (2008). The ground state of embryonic stem cell self-renewal. Nature, 453(7194), 519–523.
5. Chou, Y.F., Chen, H.H., Eijpe, M., Yabuuchi, A., Chenoweth, J.G., Tesar, P., et al. (2008). The Growth Factor Environment Defines Distinct Pluripotent Ground States in Novel Blastocyst-Derived Stem Cells. 135(3), 449–461.
6. Han, D. W., Greber, B., Wu, G., Tapia, N., Arauzo-Bravo, M. J., Ko, K., et al. (2011). Direct reprogramming of fibroblasts into epiblast stem cells. Nature Cell Biology, 13(1), 66–71.
7. Roberts, R. M., Telugu, B. P. V. L., & Ezashi, T. (2009). Induced pluripotent stem cells from swine (Sus scrofa) why they may prove to be important. Cell Cycle, 8(19), 3078–3081.
8. Esteban, M. A., Xu, J., Yang, J., Peng, M., Qin, D., Li, W., et al. (2009). Generation of induced pluripotent stem cell lines from Tibetan miniature pig. Journal of Biological Chemistry, 284(26), 17634–17640.
9. Wu, Z., Chen, J., Ren, J., Bao, L., Liao, J., Cui, C., et al. (2009). Generation of pig induced pluripotent stem cells with a drug-inducible system. Journal of Molecular Cell Biology, 1(1), 46–54.
10. Montserrat, N., de Onate, L., Garreta, E., Gonzalez, F., Adamo, A., Eguizabal, C., et al. (2012). Generation of feeder-free pig induced pluripotent stem cells without Pou5f1. Cell Transplantation, 21(5), 815–825.
11. Cheng, D., Guo, Y. J., Li, Z. Z., Liu, Y. J., Gao, X., Gao, Y., et al. (2012). Porcine induced pluripotent stem cells require LIF and maintain their developmental potential in early stage of embryos. PloS One, 7(12), e51778.
12. Thomson, A. J., Pierart, H., Meek, S., Bogerman, A., Sutherland, L., Murray, H., et al. (2012). Reprogramming pig fetal fibroblasts reveals a functional LIF signaling pathway. Cellular Reprogramming, 14(2), 112–122.
13. Ezashi, T., Telugu, B. P., Alexenko, A. P., Sachdev, S., Sinha, S., & Roberts, R. M. (2009). Derivation of induced pluripotent stem cells from pig somatic cells. Proceedings of the National Academy of Sciences of the United States of America, 106(27), 10993–10998.
14. West, F. D., Terlouw, S. L., Kwon, D. J., Mumaw, J. L., Dhara, S. K., Hasneen, K., et al. (2010). Porcine induced pluripotent stem cells produce chimeric offspring. Stem Cells and Development, 19(8), 1211–1220.
15. West, F. D., Uhl, E. W., Liu, Y., Stowe, H., Lu, Y., Yu, P., et al. (2011). Brief report: chimeric pigs produced from induced pluripotent stem cells demonstrate germline transmission and no evidence of tumor formation in young pigs. Stem Cells, 29(10), 1640–1643.
16. Plath, K., & Lowry, W. E. (2011). Progress in understanding reprogramming to the induced pluripotent state. Nature Reviews. Genetics, 12(4), 253–265.
17. Li, R. H., Liang, J. L., Ni, S., Zhou, T., Qing, X. B., Li, H. P., et al. (2010). A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell, 7(1), 51–63.
18. Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H. K., Beyer, T. A., Datti, A., et al. (2010). Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell, 7(1), 64–77.
19. Chen, J., Liu, J., Yang, J., Chen, Y., Ni, S., Song, H., et al. (2011). BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Research, 21(1), 205–212.
20. Gao, Y., Guo, Y. J., Duan, A. Q., Cheng, D., Zhang, S. Q., & Wang, H. Y. (2014). Optimization of culture conditions for maintaining porcine induced pluripotent stem cells. DNA and Cell Biology, 33(1), 1–11.
21. Zhang, S., Chen, S., Li, W., Guo, X., Zhao, P., Xu, J., et al. (2011). Rescue of ATP7B function in hepatocyte-like cells from Wilson’s disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Human Molecular Genetics, 20(16), 3176–3187.
22. Rodriguez, A., Allegrucci, C., & Alberio, R. (2012). Modulation of pluripotency in the porcine embryo and iPS cells. PloS One, 7(11), e49079.
23. Fujishiro, S., Nakano, K., Mizukami, Y., Azami, T., Arai, Y., Matsunari, H., et al. (2013). Generation of naive-like porcine-induced pluripotent stem cells capable of contributing to embryonic and fetal development. Stem Cells and Development, 22(3), 473–482.
24. Maherali, N., & Hochedlinger, K. (2009). Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Current Biology, 19(20), 1718–1723.
25. Xiao, S., Xie, D., Cao, X. Y., Yu, P. F., Xing, X. Y., Chen, C. C., et al. (2012). Comparative epigenomic annotation of regulatory DNA. Cell, 149(6), 1381–1392.
26. Cao, S., Han, J., Wu, J., Li, Q., Liu, S., Zhang, W., et al. (2014). Specific gene-regulation networks during the pre-implantation development of the pig embryo as revealed by deep sequencing. BMC Genomics, 15, 4.
27. Telugu, B. P., Ezashi, T., Sinha, S., Alexenko, A. P., Spate, L., Prather, R. S., et al. (2011). Leukemia inhibitory factor (LIF)-dependent, pluripotent stem cells established from inner cell mass of porcine embryos. Journal of Biological Chemistry, 286(33), 28948–28953.
28. Buganim, Y., Faddah, D. A., Cheng, A. W., Itskovich, E., Markoulaki, S., Ganz, K., et al. (2012). Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell, 150(6), 1209–22.
29. Hassani, S. N., Totonchi, M., Gourabi, H., Scholer, H. R., & Baharvand, H. (2014). Signaling roadmap modulating naive and primed pluripotency. Stem Cells and Development, 23(3), 193–208.
30. Heinrich, E. M., & Dimmeler, S. (2012). MicroRNAs and stem cells control of pluripotency, reprogramming, and lineage commitment. Circulation Research, 110(7), 1014–1022.
31. Worringer, K. A., Rand, T. A., Hayashi, Y., Sami, S., Takahashi, K., Tanabe, K., et al. (2014). The let-7/LIN-41 pathway regulates reprogramming to human induced pluripotent stem cells by controlling expression of prodifferentiation genes. Cell Stem Cell, 14(1), 40–52.
32. Tsukiyama, T., & Ohinata, Y. (2014). A modified EpiSC culture condition containing a GSK3 inhibitor can support germline-competent pluripotency in mice. PloS One, 9(4), e95329.
33. Chang, K. H., & Li, M. (2013). Clonal isolation of an intermediate pluripotent stem cell state. Stem Cells, 31(5), 918–927.
34. Gafni, O., Weinberger, L., Mansour, A. A., Manor, Y. S., Chomsky, E., Ben-Yosef, D., et al. (2013). Derivation of novel human ground state naive pluripotent stem cells. Nature, 504(7479), 282–6.
35. Ware, C. B., Nelson, A. M., Mecham, B., Hesson, J., Zhou, W. Y., Jonlin, E. C., et al. (2014). Derivation of naive human embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 111(12), 4484–4489.
36. Xu, J., Lamouille, S., & Derynck, R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Research, 19(2), 156–172.
37. Ichida, J. K., Blanchard, J., Lam, K., Son, E. Y., Chung, J. E., Egli, D., et al. (2009). A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell, 5(5), 491–503.
38. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26(1), 101–106.
39. Brons, I. G., Smithers, L. E., Trotter, M. W., Rugg-Gunn, P., Sun, B., de Sousa, C., Lopes, S. M., et al. (2007). Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature, 448(7150), 191–5.
40. Yang, J. Y., Mumaw, J. L., Liu, Y. B., Stice, S. L., & West, F. D. (2013). SSEA4-positive pig induced pluripotent stem cells are primed for differentiation into neural cells. Cell Transplantation, 22(6), 945–959.
41. Festuccia, N., Osorno, R., Halbritter, F., Karwacki-Neisius, V., Navarro, P., Colby, D., et al. (2012). Esrrb is a direct nanog target gene that can substitute for nanog function in pluripotent cells. Cell Stem Cell, 11(4), 477–490.
42. Feng, B., Jiang, J., Kraus, P., Ng, J. H., Heng, J. C., Chan, Y. S., et al. (2009). Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nature Cell Biology, 11(2), 197–203.
43. Martello, G., Sugimoto, T., Diamanti, E., Joshi, A., Hannah, R., Ohtsuka, S., et al. (2012). Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell, 11(4), 491–504.
44. Greve, T. S., Judson, R. L., & Blelloch, R. (2013). microRNA control of mouse and human pluripotent stem cell behavior. Annual Review of Cell and Developmental Biology, 29, 213–39.